Found 33 matching trials
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination PHASE3 The study will evaluate the safety, tolerability, and immunogenicity of VAX...
Show More Status
Active Not Recruiting
Location
Chinle Center for Indigenous Health
Learn More & Join Trial
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants PHASE2 The purpose of this study is to learn about the safety of a new pneumococca...
Show More Status
Active Not Recruiting
Location
Northwest Arkansas Pediatric Clinic
Learn More & Join Trial
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents PHASE3 The purpose of this study is to learn about the safety of a new pneumococca...
Show More Location
Alabama Clinical Therapeutics, LLC Birmingham Pediatric Associates
Learn More & Join Trial
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. PHASE3 The purpose of this study is to learn about the safety of a new pneumococca...
Show More Location
Alabama Clinical Therapeutics, LLC Birmingham Pediatric Associates
Learn More & Join Trial
Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3) PHASE3 This is a phase 3, randomized, double-blind, active comparator-controlled s...
Show More Location
Central Research Associates ( Site 0067)
Learn More & Join Trial
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age PHASE3 This is a phase 3 randomized, modified double-blind study whose purpose is ...
Show More Location
Northwest Arkansas Pediatric Clinic- Site Number : 8400039
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults PHASE2 The objective of the study is to evaluate the safety and tolerability of a ...
Show More Location
Accel Research Sites-Birmingham Clinical Research Unit
Learn More & Join Trial
Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults PHASE3 The purpose of this study is to assess the ability of RSVPreF3 OA investiga...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults PHASE1 The purpose of this study is to learn about the safety and immune effects o...
Show More Location
Alliance for Multispecialty Research, LLC
Learn More & Join Trial
Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs PHASE4 This clinical trial aims to evaluate the effect of temporary methotrexate (...
Show More Location
Reumatology division of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
Learn More & Join Trial